Durability of the survival effect of cardiac resynchronization therapy by level of left ventricular functional improvement: Fate of " nonresponders"

Heart Rhythm

Volumn 11, Issue 3, 2014, Pages 412-416

  Rickard, John ^a   Cheng, Alan ^a   Spragg, David ^a   Bansal, Sandeep ^a   Niebauer, Mark ^b   Baranowski, Bryan ^b   Cantillon, Daniel J ^b   Tchou, Patrick J ^b   Grimm, Richard A ^b   Wilson Tang, W H ^b   Wilkoff, Bruce L ^b   Varma, Niraj ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiac resynchronization therapy; Long term outcomes; Remodeling

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; LONG-TERM OUTCOMES; REMODELING;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84894586036     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.11.025     Document Type: Article

References (22)

1. L.A. Saxon, T. De Marco, J. Schafer, K. Chatterjee, U.N. Kumar, and E. Foster VIGOR Congestive Heart Failure Investigators. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling Circulation 105 2002 1304 1310
2. M.G. St. John Sutton, T. Plappert, and W.T. Abraham et al. Multicenter InSync Randomized Clinical Evaluation(MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure Circulation 107 2003 1985 1990
3. M. St. John Sutton, S. Ghio, and T. Plappert et al. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure Circulation 120 2009 1858 1865
4. A.J. Moss, W.J. Hall, and D.S. Cannom et al. MADIT-CRT Trial Investigators Cardiac- resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361 2009 1329 1338
5. C.M. Yu, G.B. Bleeker, and J.W. Fung et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy Circulation 112 2005 1580 1586
6. C. Ypenburg, R.J. van Bommel, and J.W. Borleffs et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow up J Am Coll Cardiol 53 2009 483 490
7. S.D. Solomon, E. Foster, M. Bourgoun for the MADIT-CRT Investigators Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter Automatic Defibrillator Implantation Trial - Cardiac Resynchronization Therapy Circulation 122 2010 985 992
8. D.H. Birnie, and A.S. Tang The problem of non-response to cardiac resynchronization therapy Curr Opin Cardiol 219 2006 20 26
9. F. Ruschitzka The challenge of non-responders to cardiac resynchronization therapy: lessons learned from oncology Heart Rhythm 9 2012 S14 S17
10. R.M. Lang, M. Bierig, and R.B. Devereux et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
11. B. Efron The efficiency of Cox's likelihood function for censored data J Am Stat Assoc 72 1977 557 565
12. J.G. Cleland, J.C. Daubert, and E. Dermann et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
13. J.G. Cleland, J.C. Daubert, and E. Erdmann et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 16 2006 1928 1932
14. M. Manne, J. Rickard, N. Varma, M.K. Chung, and P. Tchou Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival Pacing Clin Electrophysiol 36 2013 970 977
15. H.J. Shenkman, V. Pampati, and A.K. Khandelwal et al. Congestive heart failure and QRS duration: establishing prognosis study Chest 122 2002 528 534
16. V. Gottipaty, S. Krellis, and L. Fei et al. The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis in patients with chronic congestive heart failure [abstract] J Am Coll Cardiol 33 1999 145A
17. N.C. Wang, A.P. Maggioni, and M.A. Konstam et al. Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction JAMA 299 2008 2656 2666
18. American Cancer Society. Cancer Facts and Figures 2013. Atlanta, GA: American Cancer Society; 2013.
19. W. Mullens, and W.H. Tang Optimizing cardiac resynchronization therapy in advanced heart failure Congest Heart Fail 17 2011 147 151
20. W. Mullens, R.A. Grimm, and T. Verga et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program J Am Coll Cardiol 53 2009 765 773
21. R.K. Altman, K.A. Parks, and C.L. Schlett et al. Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes Eur Heart J 17 2012 2181 2188
22. B.K. Fornwalt, W.W. Sprague, and P. BeDell et al. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy Circulation 121 2010 1985 1991